Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine

被引：10
|
作者：
Smith, S. P. [1 ]
Baxendale, H. E. [2 ,3 ]
Sterling, J. C. [1 ,3 ]
机构：
[1] Cambridge Univ Hosp, NHS Fdn Trust, Dept Dermatol, Cambridge CB2 0QQ, England
[2] Papworth Hosp, NHS Fdn Trust, Dept Clin Immunol, Papworth Everard, England
[3] Univ Cambridge, Dept Med, Cambridge, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2017年 / 42卷 / 03期
关键词：
HPV VACCINATION; CUTANEOUS WARTS; RESOLUTION; RESPONSES;
D O I：
10.1111/ced.13038
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Human papillomavirus (HPV)-induced cutaneous warts are potentially serious and debilitating. In immunosuppressed patients, these warts may be resistant to standard therapies. We report a case of a young patient with a primary immune deficiency whose recalcitrant cutaneous warts regressed completely following administration of a quadrivalent HPV vaccine.
引用
收藏
页码：306 / 308
页数：3
相关论文
共 50 条
  • [21] Comment on: "Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts"
    Taheri, Arash
    Mansoori, Parisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : E101 - E102
  • [22] Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
    Chao, C.
    Klein, N. P.
    Velicer, C. M.
    Sy, L. S.
    Slezak, J. M.
    Takhar, H.
    Ackerson, B.
    Cheetham, T. C.
    Hansen, J.
    Deosaransingh, K.
    Emery, M.
    Liaw, K. -L.
    Jacobsen, S. J.
    JOURNAL OF INTERNAL MEDICINE, 2012, 271 (02) : 193 - 203
  • [23] The Quadrivalent Human Papillomavirus Vaccine: Erythema Multiforme and Cutaneous Side Effects after Administration
    Perez-Carmona, Lucia
    Aguayo-Leiva, Ingrid
    Gonzalez-Garcia, Carmen
    Jaen-Olasolo, Pedro
    DERMATOLOGY, 2010, 221 (03) : 197 - 200
  • [24] Aluminum Granuloma After Administration of the Quadrivalent Human Papillomavirus Vaccine. Report of a Case
    Marsee, Derek K.
    Williams, John M.
    Velazquez, Elsa F.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2008, 30 (06) : 622 - 624
  • [25] Reply to: "Comment on 'Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts'"
    Nofal, Ahmad
    Marei, Ayman
    Ibrahim, Al-shimaa M.
    Nofal, Eman
    Nabil, Manal
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : E103 - E103
  • [26] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS, 2011, 71 (05) : 591 - 602
  • [27] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS IN R&D, 2012, 12 (04) : 235 - 238
  • [28] The Impact of Varying Numbers of Quadrivalent Human Papillomavirus Vaccine Doses on Anogenital Warts in the United States: A Database Study
    Zeybek, Burak
    Lin, Yu-Li
    Kuo, Yong-Fang
    Rodriguez, Ana M.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 189 - 194
  • [29] Alaska Native adolescent views on cervical cancer, the human papillomavirus (HPV), genital warts and the quadrivalent HPV vaccine
    Kemberling, Melissa
    Hagan, Kyla
    Leston, Jessica
    Kitka, Sassa
    Provost, Ellen
    Hennessy, Thomas
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2011, 70 (03) : 245 - 253
  • [30] Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
    Choi, Hoon
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 361 - 368
12345